J. Porter

发表

A Novel Post-translational Modification Involving Bromination of Tryptophan

J. Rivier, J. McIntosh, B. Olivera, 1997, The Journal of Biological Chemistry.

Dose relationship between GnRH antagonists and pituitary suppression.

J. Rizo, L. Gierasch, A. Hagler, 1996, Human reproduction.

Identification of alkylidene hydrazides as glucagon receptor antagonists.

A. Kuki, D. Murphy, A. Polinsky, 2001, Journal of medicinal chemistry.

Characterization of Gonadotropin Hormone-Releasing Hormone Analogs

A. Hagler, W. Vale, J. Rivier, 1989 .

An expanded nomenclature scheme for labeling peptide fragmentations and its use with 'AMASS', a computer program for generating all possible fragment ion structures from known precursors.

J. Rivier, A. Craig, J. Porter, 1993, Biological mass spectrometry.

Gonadotropin-releasing hormone antagonists: novel members of the azaline B family.

W. Vale, J. Rivier, C. Rivier, 1995, Journal of medicinal chemistry.

Gonadotropin-releasing hormone antagonists: novel members of the azaline B family.

W. Vale, J. Rivier, C. Rivier, 1995, Journal of medicinal chemistry.

Gonadotropin-releasing hormone antagonists containing novel amino acids

W. Vale, J. Rivier, C. Rivier, 1994 .

New effective gonadotropin releasing hormone antagonists with minimal potency for histamine release in vitro.

W. Vale, J. Rivier, C. Rivier, 1986, Journal of medicinal chemistry.

Gonadotropin-releasing hormone antagonists with N omega-triazolylornithine, -lysine, or -p-aminophenylalanine residues at positions 5 and 6.

J. Rivier, A. Craig, J. Dykert, 1992, Journal of medicinal chemistry.

Novel gonadotropin-releasing hormone antagonists: peptides incorporating modified N omega-cyanoguanidino moieties.

W. Vale, J. Rivier, C. Rivier, 1991, Journal of medicinal chemistry.

Betidamino acid scan of the GnRH antagonist acyline.

J. Rivier, C. Rivier, C. Campen, 1997, Journal of medicinal chemistry.

Betidamino acids: versatile and constrained scaffolds for drug discovery.

J. Rivier, A. Craig, J. Porter, 1996, Proceedings of the National Academy of Sciences of the United States of America.

The gonadotropin-releasing hormone pituitary receptor interacts with a guanosine triphosphate-binding protein: differential effects of guanyl nucleotides on agonist and antagonist binding.

W. Vale, J. Rivier, J. Porter, 1989, Endocrinology.

Structural modifications of non-mammalian gonadotropin-releasing hormone (GnRH) isoforms: design of novel GnRH analogues

W. Vale, N. Sherwood, A. Craig, 1995, Regulatory Peptides.

Gonadotropin releasing hormone antagonists: novel structures incorporating N omega-cyano modified guanidine moieties.

D. Hahn, J. Rivier, C. Rivier, 1991, Biochemical and biophysical research communications.

Design of potent cyclic gonadotropin releasing hormone antagonists.

A. Hagler, W. Vale, J. Rivier, 1988, Journal of medicinal chemistry.

LHRH analogs as antiovulatory agents

W. Vale, J. Rivier, C. Rivier, 1984 .

Design of potent dicyclic (4-10/5-8) gonadotropin releasing hormone (GnRH) antagonists.

S. Lahrichi, J. Rivier, C. Rivier, 2000, Journal of medicinal chemistry.

Design of potent dicyclic (1-5/4-10) gonadotropin releasing hormone (GnRH) antagonists.

J. Rivier, C. Rivier, A. Craig, 2000, Journal of medicinal chemistry.

Design of Monocyclic (1—3) and Dicyclic (1—3/4—10) Gonadotropin Releasing Hormone (GnRH) Antagonists.

J. Rivier, C. Rivier, J. Porter, 2000 .

Defining the active conformation of gonadotropin releasing hormone (GnRH) through design and conformational analysis of constrained GnRH analogs

J. Rizo, L. Gierasch, A. Hagler, 1994 .

DESIGN, COMPUTER DERIVED STRUCTURE AND BIOLOGICAL ACTIVITY OF THREE BICYCLIC GONADOTROPIN RELEASING HORMONE (GnRH) ANTAGONISTS

A. Hagler, J. Rivier, C. Rivier, 1990 .

Design of Potent Dicyclic (4—10/5—8) Gonadotropin Releasing Hormone (GnRH) Antagonists.

J. Rivier, C. Rivier, J. Porter, 2000 .

Design of monocyclic (1-3) and dicyclic (1-3/4-10) gonadotropin releasing hormone (GnRH) antagonists.

S. Lahrichi, J. Rivier, C. Rivier, 2000, Journal of medicinal chemistry.

Preparative-scale synthesis and reversed-phase purification of a gonadotropin-releasing hormone antagonist.

J. Porter, J. Rivier, J. Boublik, 1989, Journal of chromatography.